Project PERCH brings together 18 European countries and 34 partner organizations with the objective of contributing to the implementation of Europe’s Beating Cancer Plan. PERCH aligns with the World Health Organization’s (WHO) “90-70-90” strategy, aiming to achieve at least 90% HPV vaccination coverage among girls, and potentially boys, by the age of 15 years.
Project objectives are:
Subscribe to PERCH newsletter and get the latest updates from European Partnership to Contrast HPV
As part of the Joint Action PERCH (PartnERship to Contrast HPV), the Italian National Institute of Health (Istituto Superiore di Sanità – ISS) has launched a powerful and creative campaign
PERCH at EUROGIN 2025: To Improve HPV Vaccination Coverage Across Europe At the EUROGIN 2025 conference in Porto on March 18th, Assist. Prof. Urška Ivanuš, MD, PhD, and lead of
As part of the Joint Action PERCH (PartnERship to Contrast HPV), the Italian National Institute of Health (Istituto Superiore di Sanità – ISS) has launched a powerful and creative campaign
PERCH at EUROGIN 2025: To Improve HPV Vaccination Coverage Across Europe At the EUROGIN 2025 conference in Porto on March 18th, Assist. Prof. Urška Ivanuš, MD, PhD, and lead of
As part of the Joint Action PERCH (PartnERship to Contrast HPV), the Italian National Institute of Health (Istituto Superiore di Sanità – ISS) has launched a powerful and creative campaign to raise awareness about the importance of HPV vaccination. To mark European Immunization Week 2025, ISS unveiled “Proteggi il domani”
PERCH at EUROGIN 2025: To Improve HPV Vaccination Coverage Across Europe At the EUROGIN 2025 conference in Porto on March 18th, Assist. Prof. Urška Ivanuš, MD, PhD, and lead of Work Package 2 (WP2), presented the latest developments from Project PERCH in the field of HPV communication. Her presentation, titled
PERCH General Assembly Highlights Achievements and Future Plans On December 9, 2024, the PERCH consortium gathered for its General Assembly in Paris, bringing together in-person and online participants from across Europe, including consortium members, Scientific Advisory Board members, and Governmental Advisory Board members. The meeting focused on reviewing project milestones,
As part of Work Package 4 (WP4) Integration and Sustainability and Work Package 2 (WP2) Communication and Dissemination, the PERCH initiative aims to improve the capacity of European Member States (MS) to effectively plan and implement HPV vaccination actions and campaigns. Task 4.6 (WP4) focuses on the launch of vaccination
PERCH GENERAL ASSEMBLY Final Results Timing: 13th June 2025, 09:00 – 15:00 CET Istituto Superiore di Sanità, Rome Photogallery Download AGENDA
EU4Health Projects on HPV: Final Results. What’s the Next? June 12th, 2025 organized by ISTITUTO SUPERIORE DI SANITÀ National Center for Global Health as part of the project Partnership to Contrast HPV-PERCH Photogallery Download AGENDA
PERCH WP2 final face-to-face meeting Presentation of National HPV communication strategies Date: 11th of June Location: Istituto Superiore di Sanità, Rome, Italy Photogallery Download AGENDA
The PERCH WP2 meeting produced valuable results On 24 and 25 April 2024, health and communication experts from the PERCH partner countries met in person in Ljubljana and via Zoom. The main purpose of the PERCH WP2 meeting was to facilitate discussions and collaboration between the participating countries on the
Subscribe to PERCH newsletter and get the latest updates from European Partnership to Contrast HPV
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not re!ect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
